Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

Journal of Clinical Investigation

Volumn 105, Issue 11, 2000, Pages 1527-1536

  Murohara, Toyoaki ^a,c   Ikeda, Hisao ^a   Duan, Junli ^a   Shintani, Satoshi ^a   Sasaki, Ken Ichiro ^a   Eguchi, Hiroyuki ^a   Onitsuka, Ichiro ^a   Matsui, Kazuo ^b   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukuda Hospital   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ARTICLE; BLOOD TRANSFUSION; CELL MIGRATION; COLONY FORMING CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SPINDLE CELL; STEM CELL; UMBILICAL CORD BLOOD;

EID: 0034129573     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8296     Document Type: Article

References (68)

1. Yanagisawa-Miwa, A., et al. 1992. Salvage of infarct myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1401-1403.
2. 165. Lancet. 348:370-374.
3. Pearlman, J.D., et al. 1995. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat. Med. 1:1085-1089.
4. Baumgartner, I., et al. 1998. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1114-1123.
5. Losordo, D.W., et al. 1998. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 98:2800-2804.
6. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
7. Schaper, W., Brahander, M.D., and Lewi, P. 1971. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ. Res. 28:671-679.
8. Risau, W., et al. 1988. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development. 102:471-478.
9. Risau, W. 1995. Differentiation of endothelium. FASEB J. 9:926-933.
10. Pardanaud, L., Altman, C., Kitos, P., and Dieterien-Lievre, F. 1989. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development. 105:473-485.
11. Carmeliet, P., and Collen, D. 1998. Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int. 53:1519-1549.
12. Flamme, I., and Risau, W. 1992. Induction of vasculogenesis and hematopoiesis in vitro. Development. 116:435-439.
13. Weiss, M., and Orkin, S.H. 1996. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J. Clin. Invest. 97:591-595.
14. Harzopoulos, A.K., Folkman, J., Vasile, E., Eiselen, G.K., and Rosenberg, R.D. 1998. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development. 125:1457-1468.
15. Asahara, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:965-967.
16. Isner, J.M., and Asahara, T. 1999. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103:1231-1236.
17. Nakahara, T., and Ogawa, M. 1982. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono-and multipotential hemopoietic progenitors. J. Clin. Invest. 70:1324-1328.
18. Mayani, H., and Lansdorp, P.M. 1994. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood. 83:2410-2417.
19. Vaziri, H., et al. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA. 91:9857-9860.
20. de La Selle, V., Gluckman, E., and Bruley-Rosset, M. 1996. Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood. 87:3977-3983.
21. Gluckman, E., et al. 1989. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321:1174-1178.
22. Broxmeyer, H.E., et al. 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA. 86:3828-3832.
23. Wagner, J.E., Kernan, N.A., Steinbuch, M., Broxmeyer, H.E., and Gluckman, E. 1995. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 346:214-219.
24. Kurtzberg, J., et al. 1996. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N. Engl. J. Med. 335:157-166.
25. Gluckman, E., et al. 1997. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337:373-381.
26. Chen, C.H., et al. 1994. Automated enumeration of CD34+ cells in peripheral blood and bone marrow. J. Hematother. 3:3-13.
27. Murohara, T., Delyani, J.A., Albelda, S.M., and Lefer, A.M. 1996. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol. 156:3550-3557.
28. Garlanda, C., and Dejana, E. 1997. Heterogeneity of endothelial cells. Specific markers. Arterioscler. Thromb. Vasc. Biol. 17:1193-1202.
29. Voyta, J.C., Via, D.P., Butterfield, C.E., and Zetter, B.R. 1984. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99:2034-2040.
30. Kojima, H., et al. 1998. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70:2446-2453.
31. Ziada, A.M., Hudlicka, O., Tyler, K.R., and Wright, A.J. 1984. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc. Res. 18:724-732.
32. Murohara, T., et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:2567-2578.
33. Murohara, T., et al. 1998. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 97:99-107.
34. Kroll, J., and Waltenberger, J. 1998. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252:743-746.
35. Ku, D.D., Zaleski J.K., Liu, S., and Brock, T.A. 1993. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265:H586-H592.
36. van der Zee, R., et al. 1997. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 95:1030-1037.
37. Fulton, D., et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:597-601.
38. Dimmeler, S., et al. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:601-605.
39. Takahashi, T., et al. 1999. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434-438.
40. Asahara, T., et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18:3964-3972.
41. Nishikawa, S., et al. 1998. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development. 125:1747-1757.
42. Ito, A., Nomura, S., Hirota, S., Suda, T., and Kitamura, Y. 1995. Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice. Lab. Invest. 72:532-538.
43. Krause, D.S., Fackler, M.J., Civin, C.I., and May, W.S. 1996. CD34: structure, biology, and clinical utility. Blood. 87:1-13.
44. Millauer, B., et al. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:835-846.
45. Yamaguchi, T.P., Dumont, D.J., Conlon, R.A., Breitman, M.L., and Rossant, J. 1993. flk-1, and flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development. 118:489-498.
46. Eichmann, A., et al. 1997. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl. Acad. Sci. USA 94:5141-5146.
47. Sato, T.N., et al. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
48. Schnurch, H., and Risau, W. 1993. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development. 119:957-968.
49. Fina, L., et al. 1990. Expression of the CD34 gene in vascular endothelial cells. Blood. 75:2417-2426.
50. + cells in normal and pathological bone marrow biopsies by OBEND10 monoclonal antibody. Leukemia. 5:1026-1030.
51. Matthews, W., et al. 1991. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA. 88:9026-9030.
52. Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A., and Satou, Y. 1995. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 55:5687-5692.
53. Yano, M., et al. 1997. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood. 89:4317-4326.
54. Civin, C.I., et al. 1984. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a. J. Immunol. 133:157-165.
55. Katz, F., Tindle, R.W., Sutherland, D.R., and Greaves, M.D. 1985. Identification of a membrane glycoprotein associated with hemopoietic progenitor cells. Leuk. Res. 9:191-198.
56. Andrews, R.G., Singer, J.W., and Bernstein, I.D. 1986. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood. 67:842-845.
57. Rafii, S., et al. 1995. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. 60:1627-1632.
58. Shi, Q., et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood. 92:362-367.
59. Bhatia, M., Bonnet, D., Murdoch, B., Gan, O.I., and Dick, J.E. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4:1038-1045.
60. Rafii, S. 2000. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105:17-19.
61. Peichev, M., et al. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 95:952-958.
62. Solovey, A., et al. 1997. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337:1584-1590.
63. Mutin, M., et al. 1999. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood. 93:2951-2958.
64. Lin, Y., Weisdorf, D.J., Solovey, A., and Hebbel, R.P. 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105:71-77.
65. Wood, H.B., May, G., Healy, L., Enver, T., and Morriss-Kay, G.M. 1997. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood. 90:2300-2311.
66. Dieterlen-Lievre, F., and Martin, C. 1981. Diffuse intraembryonic hemopoiesis in normal and chimeric avian development. Dev. Biol. 88:180-191.
67. Kalka, C., et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA. 97:3422-3427.
68. Crisa, L., et al. 1999. Human cord blood progenitors sustain rhymic T-cell development and a novel form of angiogenesis. Blood. 94:3928-3940.